awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33881234-692D83AC-BD78-4860-8ED3-F7F6AFC07621
Q33881234-692D83AC-BD78-4860-8ED3-F7F6AFC07621
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33881234-692D83AC-BD78-4860-8ED3-F7F6AFC07621
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability.
P2860
Q33881234-692D83AC-BD78-4860-8ED3-F7F6AFC07621
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33881234-692D83AC-BD78-4860-8ED3-F7F6AFC07621
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b347476f8861f80ea58d5dcdcaa6e8cd512f92fb
P2860
Jump-starting the immune system: prime-boosting comes of age.